Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma

Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma

Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.

Inclusion Criteria:

1. Patients must be affected by HCC
2. Patients must have diminished renal function (GFR<60 ml/min/1.73m^2)
3. Patients must be 18 years old or older
4. Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the TACE procedure.
5. Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

1. Subjects under the age of 18
2. Patients currently on dialysis
3. Pregnant women